Sanofi
SNY News Today: Stay Updated with the Latest Sanofi News in Real Time
Find SNY news now at Meyka AI. Stay informed with the latest Sanofi stocks updates, including price news, market analysis, and expert insights.
INTRADAY SANOFICONR.NS Sanofi CH (NSE) 4,179.80 Feb 2026 earnings: watch margins
SANOFICONR.NS stock analysis ahead of Feb 2026 earnings; price INR 4,179.80, margin drivers and short-term forecast
SNY Stock Today, February 13: CEO Ousted; Garijo Tapped to Fix Pipeline
Sanofi CEO Paul Hudson is out and Belen Garijo will take over April 29. We break down what this means for Sanofi stock SNY, the pipeline setbacks, and key U.S. risks.
SNY Stock Today: January 30 RSV Wave in Germany Puts Beyfortus in Focus
Sanofi stock edges into focus in Germany as RKI confirms the RSV wave. STIKO’s Beyfortus (nirsevimab) recommendation and early hospital feedback on milder infant cases point to robust seasonal demand.
€0.03 close for Deinove SA (ALDEI.PA, EURONEXT) 29 Jan 2026: high volume insight
ALDEI.PA stock closed at €0.0265 on 29 Jan 2026 with heavy volume; active trading and analyst-grade outlook
Q4 beat lifts Sanofi (SAN.PA EURONEXT): 29 Jan 2026 earnings focus on pipeline
SAN.PA stock: Q4 beat, €1.20B buyback and pipeline focus shape outlook for investors
SNW.DE Sanofi (XETRA) Q4 earnings 29 Jan 2026: EPS, guidance and market signal
SNW.DE stock: Sanofi reports Q4 on 29 Jan 2026; read EPS, PE, Meyka forecast and price targets for trading on XETRA
ALSEN.PA Sensorion SA +22.06% pre-market 29 Jan 2026: Sanofi €60.00M backs trials
Pre-market: ALSEN.PA stock up 22.06% on Sanofi €60.00M deal. Quick analysis, grade, and price targets from Meyka AI
SAN.PA Sanofi pre-market 27 Jan 2026: earnings ahead, amlitelimab momentum
SAN.PA stock pre-market earnings preview for 27 Jan 2026, pipeline update and Meyka AI forecast for investors
SNY Stock Today: January 26 RSV Wave Warning May Boost Beyfortus Demand
Sanofi stock: RKI RSV warning in Germany may lift Beyfortus demand. We review today’s setup, valuation, technicals, and key near-term catalysts for DE investors.